Skip to main content
. 2004 Jan 12;141(3):449–456. doi: 10.1038/sj.bjp.0705641

Table 1.

Effects of Indomethacin, BAYu3405, mepyramine and metiamide on the contraction induced by LTB4 in the GPLP and GPPA

Group n AUC (whole) 0–10 min AUC (early) 0–1 min
GPLP      
  Control 6 325.8±18.0 17.33±2.42
  BAY 3 104.2±17.6a 6.84±1.41a
  Indo 3 102.9±30.4a 5.02±1.78a
  Mep+Met 6 286.6±21.6 9.23±1.06a
  BAY+Mep+Met 3 143.5±21.4a,b −0.71±0.91a,b
  Indo+Mep+Met 3 95.6±6.8a,b 0.28±0.12a,b
GPLP with U-75302 (1 μM)   0–10 min 0–1 min
  Control 4 188.6±36.9 6.40±0.97
  BAY 4 61.6±15.1a 0.67±0.38a
  Mep+Met 4 215.9±32.1 7.16±1.62
  BAY+Mep+Met 4 69.9±24.8a,b 0.26±0.41a,b
GPPA   0–5 min 0–1 min
  Control 7 57.7±10.9 15.83±2.41
  BAY 7 27.0±9.4a 11.11±3.13
  Mep+Met 7 19.7±6.1a 4.68±1.31a
  BAY+Mep+Met 7 1.2±0.5a −0.05±0.08a,c

Each data represent the mean±s.e.m. of n experiments. LTB4 was administered at 100 nM (GPLP) and 1 μM (GPPA). BAY, Indo, Mep and Met means BAYu3405 3 μM, indomethacin 10 μM, mepyramine 1 μM and metiamide 1 μM, respectively.

a

P<0.05 vs control

b

P<0.05 vs Mep+Met (Tukey test)

c

P<0.05 vs BAY or Indo.